Assembly factors play a critical role in the biogenesis of the mitochondrial respiratory chain, which includes complexes I-IV. Complexes I, III and IV are found in a high molecular weight structure known as the respiratory chain supercomplex or respirasome. A number of proteins are frequently suggested to be required for supercomplex assembly, including the homolog of hypoxia inducible gene 1 domain family member HIGD2A which has been shown to stabilize the respirasome in yeast. We show that loss of HIGD2A in human cells results in impaired complex IV activity and accumulation of complex IV assembly intermediates. Using a novel pulseproteomics approach we show HIGD2A functions in the stabilization of newly translated mtDNA-encoded COX3, and its loss leads to turnover of COX3 and partner subunits found within the COX3 module. While this leads to the presence of an altered supercomplex, we show it to represent a supercomplex harboring misassembled complex IV lacking COX3. We conclude HIGD2A is a classical assembly factor required for building the COX3 module of human complex IV.
Introduction
The electron transport chain (ETC) of human mitochondria is comprised of four multiprotein complexes (Complex I-IV) embedded in the inner mitochondrial membrane (IMM). In a process known as oxidative phosphorylation the ETC takes electrons from metabolites and uses their energy to build a proton gradient across the IMM, which in turn powers production of ATP through Complex V (F1Fo ATP Synthase). Complex IV (CIV; CcO; cytochrome c oxidase) is the fourth and last enzyme of the ETC and catalyzes the transfer of electrons from cytochrome c to molecular oxygen. Complexes I, III and IV have been shown to exist in several higher order structures known as respiratory chain supercomplexes or respirasomes [1] [2] [3] [4] . These structures have been suggested to reduce production of reactive oxygen species (ROS), improve complex stability and/or distribution throughout the protein dense environment of the IMM, and allow efficient channeling of substrates [3] [4] [5] [6] [7] [8] .
Complex IV is composed of 14 different subunits of dual genetic origin, the core membrane embedded subunits, COX1, COX2 and COX3 are encoded by mitochondria DNA (mtDNA) genes MT-CO1, MT-CO2 and MT-CO3, that are translated on mitochondrial ribosomes in the matrix, whereas the remaining 11 subunits are encoded by nuclear DNA, translated in the cytosol and imported into the mitochondria where they assemble with mtDNA encoded subunits. Nuclear encoded subunits can therefore be grouped into assembly modules seeded by each of the mtDNA encoded subunits ( Fig. 1) [9, 10] . During complex IV biogenesis, redox active heme and copper cofactors are incorporated into COX1 and COX2, which together with COX3 form the conserved core of the enzyme. While COX3 does not have a direct role in electron transport, it is thought to play a regulatory role in modulating complex IV activity [11, 12] . Homologs of COX3 are present in complex IV throughout the tree of life [13] and mutations within MT-CO3 lead to complex IV deficiency and mitochondrial encephalopathy or myopathy [MIM 516050; 14,15] implicating the importance of COX3 in complex IV and mitochondrial function.
Biogenesis of complex IV occurs through the coordinated effort of more than 30 known assembly factors with roles including control of mitochondrial RNA stability and translation, membrane insertion of mtDNA encoded subunits, copper and heme biosynthesis and loading and stabilization of subunit modules during assembly [9, 10, 16] . While several assembly factors are known to be essential for stabilizing the modules containing COX1 and COX2, to date no assembly factors have been associated with the COX3 module (containing COX3, COX6A, COX6B and COX7A) in humans. Two assembly factors have also been suggested to support complex IV-containing supercomplex assembly, COX7A2L (SCAFI) and HIGD2A [17] . COX7A2L was originally shown to be present within the supercomplex but not in the holo form of complex IV [6] . A mouse strain harboring a truncated form of the protein lacked some forms of the supercomplexes and exhibited altered mitochondrial respiration, leading the authors to suggest the protein is required for supercomplex stability [6] . Several studies have disputed this finding [18] [19] [20] [21] [22] [23] and it is now understood that COX7A2L plays a role as a checkpoint for assembly of CIII2 into the supercomplex [23] , a result that explains the differences in supercomplex distribution observed in mitochondria lacking full length COX7A2L. Yeast (S. cerevisiae) homologs of HIGD2A (Rcf1 and Rcf2) belong to the hypoxia inducible gene 1 domain containing (HIGD) family and were originally suggested to be required for assembly and stability of the yeast CIII2/IV supercomplex [24] [25] [26] . Deletion of Rcf1 leads to impaired assembly of Cox12 and Cox13 (COX6B and COX6A in humans) into complex IV, reduced association with Rcf2, and a reduction in the levels CIII2/IV supercomplex [24] [25] [26] . Recent studies have suggested a regulatory role for Rcf1 and Rcf2 in complex IV activity [27] through association with complex IV intermediates [28] . Investigation into the function of mammalian homologs HIGD1A and HIGD2A have been limited to only a few studies. Both HIGD1A and HIGD2A were originally identified in a screen for genes upregulated during HIF1α dependent hypoxia [29, 30] . Following discovery of Rcf1 and Rcf2 in yeast supercomplex assembly, Chen et al. [26] showed that knockdown of Higd1a in mouse myoblasts had no impact on respiratory chain supercomplexes whereas, knockdown of Higd2a led to reduced amounts of CIII2/CIV and a higher-order assembly now known to be the respiratory chain megacomplex (CI2/III2/IV2) [2] . No impact was observed on the levels of holo complex IV, leading the authors to suggest Higd2a is a supercomplex assembly factor, consistent with the studies in yeast [26] . In contrast, HIGD1A has recently been suggested to associate non-stoichiometrically with an early assembly intermediate consisting of COX1 and associated subunits [10] and induce structural changes around the heme a active center altering complex IV activity during hypoxic stress [31] .
We identified HIGD2A as a protein strongly upregulated in lymphoblasts from a patient with ETC complex IV deficiency. Given that the yeast homolog of HIGD2A has been previously associated with either complex IV or respiratory chain supercomplex assembly, we aimed to clarify the function of human HIGD2A as well as its ortholog HIGD1A. Using CRISPR/Cas9 generated knockout cell lines we show that loss of HIGD1A leads to a modest defect in mitochondrial oxygen consumption and stability of subunits present within the COX1 module but does not affect complex assembly. While we find HIGD1A is indeed induced during hypoxia, this results in no apparent changes to complex IV or supercomplex assembly. Conversely, we demonstrate that loss of HIGD2A leads to a strong defect in mitochondrial respiration, complex IV assembly and activity due to impaired stability of newly translated COX3, and subsequent degradation of nuclear encoded subunits present within the COX3 module. We conclude that HIGD2A is an assembly factor involved in stabilization of MT-COX3 along with the COX3 module of complex IV.
Results

HIGD2A is upregulated in patient lymphoblasts with an isolated complex IV deficiency
We identified a patient presenting with intrauterine growth retardation, developmental delay, cortical blindness, possible deafness, lactic acidosis and cardiomyopathy. The patient died at 16 months of age. Enzymology revealed an apparently isolated complex IV defect in muscle and lymphoblasts (Table 1 ). Whole exome sequencing revealed two novel compound heterozygous missense mutations (c.1874G>A, p.Arg625His; c.665C>T p.Thr222Ile) in AARS2, which encodes for mitochondrial alanine-tRNA synthetase (MIM 612035). Both mutations are classified as class 4 or 'likely pathogenic' (PM2, PP3, PS3) using the ACMG standards and guidelines for the interpretation of sequence variants [32] . It is not uncommon to find an apparently isolated ETC enzyme defect in genetic defects that would be expected to affect multiple ETC enzymes [33] . Given that AARS2 lymphoblasts harbor an isolated complex IV defect, we utilized them to search for novel proteins involved in assembly of complex IV. We performed quantitative mass spectrometry on the patient lymphoblasts and on control lymphoblasts from three unaffected individuals, as we have done previously for patient fibroblasts [34] . We quantified the levels of 3,901 cellular proteins detected in AARS2 lymphoblasts and in at least two out of three control cell lines ( Supplemental Table S1 ), revealing significant reduction in the levels of complex IV subunits but not subunits of complexes I, III or V ( Fig. 2 ) consistent with enzymology data. HIGD2A was the most significantly upregulated protein in AARS2 lymphoblasts relative to control cell lines.
Loss of HIGD2A leads to defective assembly of complex IV
To clarify the function of HIGD2A we used CRISPR/Cas9 to generate human embryonic kidney (HEK293T) cell lines lacking its expression ( Fig. S1 ). We also generated cell lines lacking the HIGD2A ortholog HIGD1A. Loss of HIGD1A (HIGD1A KO ) led to no changes in the steady state level of complex IV subunits ( Fig. S1A ), whereas loss of HIGD2A (HIGD2A KO ) led to a strong reduction in the levels of COX2 (Fig. S1B ), the core subunit of the COX2 module, and the total loss of COX6A, a nuclear encoded subunit present within the COX3 module. To assess the assembly of complex IV and supercomplexes we performed Blue Native (BN)-PAGE. When using the weak nonionic detergent digitonin, BN-PAGE is capable of resolving stalled complex IV assembly intermediates, holo complex IV and multiple high-order supercomplex structures [10, 20, 23, 35, 36] . As can be seen in Fig. 3A , while HIGD2A KO mitochondria appear to contain the primary supercomplex assembly consisting of CI/III2/IV, we could not detect the megacomplex (CI2/III2/IV2). We also observed changes in supercomplex distribution, with a shift toward the CI/III2 assembly lacking complex IV (compare lanes 1,2, and 2,5). Additionally, HIGD2A KO [9, 16, 36] . Strikingly, no signal was observed for COX3 module subunit COX6A1, either in accumulated intermediates or mature complex IV assemblies ( Fig. 3A compare lanes 16,17) . In contrast to HIGD2A KO , mitochondria lacking HIGD1A contained normal levels and distribution of supercomplex assemblies and accumulated complex IV intermediates were not detected ( Fig. 3A) .
HIGD2A stabilizes the COX3 module of complex IV
To confirm the steady levels of complex IV subunits in HIGD2A KO mitochondria we performed quantitative massspectrometry. Mitochondrial proteins from HIGD2A KO , HIGD1A KO and control cells were digested, and tryptic peptides labeled with tandem mass tags (TMT) prior to pooled analysis and synchronous precursor selection (SPS)-MS3 based acquisition. We quantified the levels of 892 proteins present within the Mitocarta2.0 [37] inventory of mitochondrial proteins across all samples ( Supplementary Table S2 ). As can be seen in Fig. 3B (left panel) HIGD2A KO mitochondria contained a significant reduction in the levels of complex IV subunits COX3 (MT-CO3), COX6A1, COX6B1, COX7A2, as well as COX2 (MT-CO2) and NDUFA4, a subunit originally ascribed to complex I but now known to be present within complex IV [35] . Other complex IV subunits were detected but found not to be significantly altered relative to control cells. HIGD2A KO mitochondria also contained significantly increased levels of complex IV assembly factors COA4, COA6, COA7, CMC2 and COX11 [9, 16] . In contrast our, analysis of HIGD1A KO mitochondria revealed a significant reduction in the levels of a different cohort of complex IV subunits; COX1 (MT-CO1), COX4 and COX5A, as well as assembly factors SCO2 and COX18 ( Fig. 3B , right panel). COA7 was also found in HIGD1A KO mitochondria at increased abundance relative to controls. Notably, the fold change in abundance of complex IV subunits was less in HIGD1A KO (~1-1.5 fold change) than for HIGD2A KO (~2-3 fold change) consistent with the strong defect in assembly we observed for the latter (Fig. 3A ).
We used topographical heatmaps [38] to interpret our mass-spectrometry data in the context of the intact 14subunit human holo complex IV [39] and CI/III2/IV respiratory chain supercomplex [2] structures recently determined by single particle cryo-electron microscopy. Both structures were determined using complexes isolated from the same HEK293 derived human cell line used in our study. Unsupervised hierarchical clustering of knockout to control protein ratios from both cell lines revealed several clusters of co-dependent subunits from complexes I, III and IV (Fig. 4A ). The most strongly clustered cohort of proteins in HIGD2A KO belonged to the COX3 module (Figs. 4A, B). We found NDUFA4 to be strongly correlated with these proteins, suggestive of it being a subunit of the COX3 module. Mapping of our data to the supercomplex (Fig. 4C ) revealed the affected complex I and III subunits to be predominantly located at contact sites with complex IV. In contrast, loss of HIGD1A led to the comparatively weak clustering of COX1 and COX2 module subunits (Figs. 4A, D). Taken together, our data suggest that loss of HIGD2A strongly affects the COX3 module of complex IV, leads to accumulation of a crippled complex IV and its defective association with complexes I and III in the respiratory chain supercomplex.
Loss of HIGD2A leads to impaired complex IV activity
HIGD2A KO cells die in media where glucose has been replaced with galactose (data not shown), indicative of severely impaired mitochondrial respiration [36, 38] . To investigate the impact of HIGD2A and HIGD1A on mitochondrial energy generation we measured the oxygen consumption rates in our HIGD2A KO and HIGD1A KO cell lines. Cells lacking HIGD2A were significantly impaired in basal and maximal respiration ( Fig. 5A ). In contrast, HIGD1A KO had impaired basal respiration but similar maximal respiration compared to control cells leading to an increase in spare respiratory capacity. To investigate the source of the respiration defects we performed an in-gel complex IV activity assay [40] . As can be seen in Fig. 5B , the remnant complex IV found within HIGD2A KO mitochondria showed only background levels of activity. While activity was detected in the HIGD2A KO CI/III2/IV supercomplex it was reduced relative to control cells. In contrast, complex IV activity in holo complex IV as well as the supercomplex was unaltered in HIGD1A KO mitochondria. Finally, to confirm the impact of HIGD2A loss on complex IV activity in vivo we measured complex IV-linked respiration [41] . Briefly, the electron donor N,N,N′,N′-Tetramethyl-p-phenylenediamine (TMPD) is provided in the presence of ascorbate to semi-permeabilized cells where it donates electrons to cytochrome c thereby bypassing complex III ( Fig. 5C ). When TMPD was added to control HEK293T cells in the presence of ADP and uncoupler FCCP, we observed maximal mitochondrial respiration that could be partially dissipated with oligomycin. Inhibition of complex IV activity with azide reveals complex IV dependent oxygen consumption. In contrast to control cells, HIGD2A KO cells had significantly impaired complex IV dependent respiration ( Fig. 5C ). Taken together, we conclude that loss of HIGD2A leads to a specific defect in complex IV enzymatic activity leading to impaired mitochondrial respiration.
HIGD2A acts on complex IV assembly independent of oxygen levels
Mammalian HIGD1A and HIGD2A were originally discovered as proteins induced following hypoxic stress [29, 30] , an insult that is known to ultimately lead to turnover of OXPHOS subunits, a reduction in oxidative capacity and an increase in glycolysis. As a way of compensation to these changes in conditions, during the initial stages of hypoxia HIGD1A has been proposed to bind complex IV and promote its activity [31] . To address whether the presence or absence of HIGD2A impacts complex IV under hypoxia we cultured HEK293T cells under an atmosphere of 1% oxygen for 0, 3 or 24 hours. Growth under these conditions led to a robust hypoxic response that we measured through TMT-based quantitative mass-spectrometry ( Supplementary Table S3 ) and western blotting ( Fig S2) . Following 24 hours under hypoxic conditions, proteins involved in glycolysis including SLC2A1, the primary plasma membrane glucose transporter, were significantly upregulated ( Fig. S2A ). In contrast, subunits of the OXPHOS machinery and the mitochondrial ribosome were significantly decreased, as expected [42] .
Stabilization of HIF1α was observed within 3 hours ( Fig. S2B ), as expected. While we found HIGD1A and complex IV subunits were indeed increased in abundance at the early stages of hypoxia (3 hours; Figs. S2B, C), the steady state level of HIGD2A was unaffected (Fig. S2B, compare lanes 1, 2) . Finally, we investigated the effects of hypoxia on assembly of complex IV and the supercomplex. Loss of neither HIGD2A nor HIGD1A altered the effects of hypoxia on assembly of the supercomplex (Fig. S2B , lower panels). Moreover, following chronic hypoxia (24 hours) we observed accumulation of the S2 intermediate in both cell lines consistent with the complexes being increasingly sensitive to destabilization in the absence of HIGD2A and HIGD1A. Taken together we conclude that HIGD2A acts on complex IV assembly independent of oxygen levels.
HIGD2A stabilizes newly translated COX3
Since our results for HIGD1A function were broadly consistent with previous studies, suggesting its involvement in regulating the COX1 module following hypoxia [31] , we focused our efforts on clarifying the function of HIGD2A under normoxic conditions. To identify the interaction partners of HIGD2A we used a retroviral system to express FLAG-tagged HIGD2A (HIGD2A FLAG ) in our HIGD2A KO cell line. Ectopic expression of HIGD2A FLAG led to rescue of supercomplex distribution and an increase in the levels of fully assembled holo complex IV ( Fig. 6A ).
HIGD2A FLAG cells were then solubilized in digitonin and complexes bound to FLAG-affinity gel, following which significantly enriched interactors were identified by affinity enrichment mass-spectrometry (AEMS). As can be seen in Fig. 6B , HIGD2A FLAG associates with subunits of complex IV with mtDNA encoded COX3 (MT-CO3) being the most strongly enriched ( Supplementary Table S4 ). Interestingly, we observed significant enrichment of complex I subunits, subunits of the mitochondrial ribosome (MRPL23, MRPL27 and MRPL50), HIGD1A as well as complex IV assembly factors COA3 [43] [44] [45] [46] and SCO1 [47, 48] , and complex I assembly factors NDUFAF2 [49] [50] [51] and NDUFAF4 [52] which is suggestive of the enriched cohort of proteins representing an assembly intermediate rather than the mature supercomplex.
Given the enrichment of the mitochondrial ribosome and the strong association of HIGD2A FLAG with mtDNAencoded COX3, we asked if mtDNA-encoded subunit translation was affected upon loss of HIGD2A. Typically, translation and stability of mtDNA-encoded subunits is assessed using a radioactive pulse-chase assay and analysis by SDS-PAGE and autoradiography [53] . Since COX2 and COX3 have a similar migration on SDS-PAGE [36] we sought to develop a mass-spectrometry based approach capable of clear differentiation between these two proteins. HIGD2A KO and control cells conditioned by overnight treatment with mtDNA translation inhibitor chloramphenicol were pulsed in media containing SILAC (stable isotope labeling by amino acids in cell culture; [54] ) amino acids 13 C6 15 N4-arginine and 13 C6 15 N2-lysine for 1, 2 and 4 hours prior to analysis by targeted massspectrometry (described in the methods). Using this technique, we could monitor the translation of 10 out of 13 mtDNA encoded subunits ( Supplementary Table S5 ) including COX2 and COX3. As can be seen in Fig. 6C we observed a significant defect in the stability of newly translated COX3 (MT-CO3) whereas translation of other mtDNA-encoded subunits was comparable to control cells.
HIGD2A KO mitochondria contain a supercomplex assembly lacking COX3
Given the apparent retention of the CI/III2/IV supercomplex in HIGD2A KO we sought an alternate approach to assess supercomplex content. We utilized a cell line we developed previously that stably expresses the FLAGtagged complex I subunit NDUFV3 in the corresponding NDUFV3 KO cell line [38] . NDUFV3 is suggested to be the final subunit added to complex I during its biogenesis and we previously used the resulting NDUFV3 FLAG cell line to enrich all detectable subunits of complexes I, III and IV [38] leading us to hypothesize that the cell line can be used to isolate the intact supercomplex. To this end we used CRISPR/Cas9 to generate HIGD2A knockout mutations in the NDUFV3 FLAG cell line. HIGD2A KO and NDUFV3 FLAG HIGD2A KO have comparable defects in complex IV assembly and supercomplex distribution ( Fig. 7A ). Next, we performed affinity enrichment and massspectrometry on both the original NDUFV3 FLAG and NDUFV3 FLAG HIGD2A KO cell lines. While NDUFV3 FLAG cells coisolated complex I, III and IV subunits as expected ( Fig. 7B ), we also detected HIGD2A, the known complex IV assembly factor COA3 and a number of other mitochondrial housekeeping proteins also detected in our original experiment ( Supplementary Table S6 and [38] ). We conclude that while the NDUFV3 FLAG eluate does not represent the purified supercomplex seen in the recent structures it likely represents a late stage assembly intermediate with a full complement of complex I, III and IV subunits and selected assembly factors. Finally, to assess the impact of HIGD2A loss on the supercomplex we performed the affinity enrichment experiment from NDUFV3 FLAG HIGD2A KO cells using NDUFV3 FLAG as the control cell line. As can be seen in Fig. 7C , while the majority of complex I, III and IV subunits were equally enriched from both cell lines, the supercomplex intermediate isolated from HIGD2A KO cells specifically lacked COX3.
Discussion
In this study we aimed to clarify the roles of hypoxia inducible gene 1 domain family members HIGD2A and HIGD1A. Although the mammalian proteins were originally identified in a screen for genes upregulated upon hypoxic stress [29, 30] the majority of work has been focused on their yeast homologs Rcf1 and Rcf2 (named for Respiratory complex factors). Three independent groups reported the functions of Rcf1 and Rcf2 as required for the formation of the respiratory chain supercomplexes, which in the yeast S. cerevisiae are comprised of complexes III and IV [24] [25] [26] . HIGD2A is thought to be the mammalian orthologue of Rcf1 and knockdown experiments in mouse myoblasts were shown to alter the distribution of complex IV-containing supercomplexes, suggesting the function of HIGD2A in supercomplex assembly is conserved from yeast to man [26] . Until now this was the only study to investigate the impact of HIGD2A loss on mammalian complex IV and supercomplex assembly, and as a result the function of HIGD2A has largely been extrapolated from yeast studies. The solution structure of yeast Rcf1 was recently solved by NMR [55] revealing two charged transmembrane helices that form salt bridges leading to formation of a homodimer. Mammalian HIGD2A lacks the charged membrane helices responsible for Rcf1 dimerization, suggesting the functions of Rcf1 and HIGD2A may differ. Despite this point of difference, the results from yeast studies are generally in agreement with our observations. For example, as we found in HIGD2A KO cells, yeast mitochondria lacking Rcf1 still contain the CIII2/IV supercomplex [25, 26, 56] (compare to Fig. 3A) . Secondly, the association of Cox12 and Cox13 (COX6B and COX6A in mammals) with complex IV is impaired in Rcf1 knockouts as it is in HIGD2A KO cells (Fig. 3B) , and likewise the remaining assembly is still capable of association with complex III [24, 25] . Finally, there also appears to be a reduction in the steady state levels of COX3 upon deletion of Rcf1 [25, 28, 56] . Indeed, in their original study Strogolova and colleagues [25] suggest that Rcf1 may interact with newly translated COX3 to regulate its association with Cox12 (COX6B) and complex IV as a means of modulating complex IV activity. While our data demonstrates a specific defect in the stability of newly translated COX3 (Fig. 6C) we were unable to determine if HIGD2A regulates translation of the subunit or stabilizes its assembly with complex IV subunits. The interaction between HIGD2A, COX3 and other complex IV and respiratory chain subunits detected in our HIGD2A FLAG affinity enrichment experiment (Fig. 6B) argues for the latter, whereas the upregulation of HIGD2A in patient lymphoblasts with an isolated complex IV defect arising from impaired translation of mtDNA-encoded subunits could be taken as an argument for transcriptional regulation (Fig. 2B ). However, our previous analysis of fibroblasts from a patient with a mutation in a subunit of the mitoribosome and therefore defective translation of all mtDNA-encoded subunits, also showed upregulation of complex IV assembly factors COX15, SCO2, SURF1 [34] suggesting their upregulation is a general response to complex IV dysfunction.
While we cannot completely exclude the possibility that HIGD2A can regulate complex IV activity, we did not observe changes in either the levels of HIGD2A or the impact of its loss on complex IV or supercomplex assembly during acute or chronic hypoxia as has been suggested for HIGD1A ( Fig. S2 ). Our conclusion is that the impact of HIGD2A on the supercomplex is a pleotropic effect due to defective complex IV assembly. The intersection of the latter assembly steps of complexes I, III and IV with supercomplex formation [8, [16] [17] [18] 20, 23] is also a major factor to be considered in interpretation of the results from ours and other studies. We detected subunits of complexes I, III and IV as well as assembly factors for complexes I and IV in our HIGD2A FLAG affinity enrichment experiment ( Fig. 6B ), suggesting that HIGD2A acts at the stage of both COX3 module integration into complex IV, and complex IV integration into the supercomplex. Moreover, in our HIGD2A KO cells we observed upregulation of complex I and III subunits found at the interface between complexes I and IV (Fig. 4A ). We hypothesize this is a mechanism to compensate for their destabilization following disruption of their interactions with complex IV subunits, in agreement with our previous results demonstrating that loss of the affected complex I subunits leads to total disassembly of the supercomplex and loss of mitochondrial respiration [38] . HIGD2A is not the first assembly factor suggested to impact supercomplex assembly indirectly [8] . The most well-known example is COX7A2L (SCAFI), which was originally found within the supercomplex but not holo complex IV [6] . A role of COX7A2L in supercomplex assembly has been disputed by multiple groups [18] [19] [20] [21] [22] [23] and the protein is now understood to act as a checkpoint for assembly of complex III into the supercomplex [23] . Another example is UQCC3 (C11orf83), which is an assembly factor suggested to stabilize the CIII2/IV form of the supercomplex [57] .
UQCC3 has also been shown to be involved in early complex III assembly and is found mutated in patients with isolated complex III deficiency [MIM 616097 ; 58] . Importantly, density for neither HIGD2A, COX7A2L nor UQCC3 has been identified in the multiple recent structures representing several different forms of the mammalian supercomplex assembly [1, 2, 4, 7] .
As part of this study we also attempted to validate the role of HIGD1A in respiratory chain assembly. The function of mammalian HIGD1A has been studied in more detail than HIGD2A and the protein has been shown to bind subunits of the COX1 module (specifically COX4, COX5A) [31] . It has been proposed that during acute hypoxia, the increased amounts of HIGD1A bind complex IV and induce structural changes around the heme a active center, increasing complex IV activity [31] . In agreement, we also showed upregulation of HIGD1A protein following 3 hours of growth under hypoxic conditions (Fig. S2 ) as well as upregulation of complex IV subunits, which was previously suggested to be a mechanism of compensation for the reduced oxygen environment [42] .
Consistent with a general function for HIGD1A in regulation of the respiratory chain during metabolic stress, Ameri and colleagues [59] showed HIGD1A to be upregulated upon glucose deprivation, however under these conditions the authors could only show an interaction with subunits of complex III and not complex IV. In contrast to these studies, under normoxic conditions, HIGD1A was most recently suggested to associate with an early complex IV assembly intermediate representing the nascent COX1 module [10] . In agreement with this, we detected HIGD1A along with other complex IV assembly factors and subunits in our HIGD2A FLAG affinity enrichment experiment (Fig.   6B ), suggestive of it being associated with complex IV during assembly. However, despite small changes in the levels of COX1 module subunits upon loss of HIGD1A (Fig. 4A, D) , the lack of a strong complex IV or supercomplex assembly defect in our HIGD1A KO (Fig. 3A) argues against its role as an assembly factor.
In conclusion, although the hypoxia induced domain family member HIGD2A has previously been implicated in the maintenance of respiratory chain supercomplexes, we find it to be involved in stabilization of mtDNA-encoded COX3. Loss of HIGD2A leads to turnover of nuclear encoded COX3 partner subunits and accumulation of a supercomplex containing a crippled complex IV. In addition to clarifying previous reports suggesting HIGD2A involvement in supercomplex assembly, our study identifies HIGD2A as the first assembly factor required for the biogenesis of the COX3 module of human complex IV.
Materials and Methods
Tissue culture and generation of cell lines
HEK293T cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM High Glucose) supplemented with 10% (v/v) fetal calf serum (FCS; CellSera), penicillin/streptomycin (Gibco) and 50 µg ml −1 uridine (Sigma) at 37°C under an atmosphere of 5% CO2. Lymphoblasts were cultured under the same conditions except that the medium was RPMI-1640 and the amount of FCS was 20% (v/v). Gene editing was performed in HEK293T (originally purchased from ATCC) and the NDUFV3 KO NDUFV3 FLAG cell line published previously [38] . Constructs for CRISPR-Cas9 genome editing were designed using the CHOPCHOP software [60] and oligonucleotides encoding gRNA sequences cloned into the pSpCas9(BB)-2A-GFP (PX458) plasmid (a gift from F. Zhang; Addgene, plasmid 48138; [61] ) as previously described [38] . The gRNA sequences used were 5'-ATGTCAGTCAAACTTACCAA for HIGD1A and 5'-ACTTACCTATGGGTACCACC for HIGD2A. Constructs were transfected using Lipofectamine LTX (ThermoFisher Scientific) according to manufacturer's instructions. Single GFP positive cells were sorted into 96 well plates and clonal populations expanded for screening by SDS-PAGE and immunoblotting as described below. To verify the CRISPR/Cas9 induced insertions and deletions (indels) genomic DNA was isolated from candidate clones using the Quick-DNA kit (Zymo Research) according to manufacturer's specifications. Oligonucleotides provided by the CHOPCHOP software [60] were used for amplification of target regions and cloning into pGEM4Z [62] for M13 primed Sanger sequencing of individual alleles as we have done previously [38] . HIGD1A KO chamber was incubated at 37°C for 3 or 24 hours as indicated. For pulse-SILAC analysis of mitochondrial translation, cells were incubated in DMEM as above with the overnight addition of 50 ug ml −1 chloramphenicol (CAP; Sigma) prior to the start of the experiment. Media was replaced with neat DMEM for SILAC (ThermoFisher Scientific) for 15 minutes following which the media was supplemented with 10% dialyzed FCS (ThermoFisher Scientific), Sodium Pyruvate (Gibco), Glutamax (Gibco), penicillin/streptomycin (Gibco), 3.5 g L −1 glucose and 0.1 mg ml −1 cycloheximide (Sigma). Following an incubation for 30 minutes at 37°C under an atmosphere of 5% CO2, media was further supplemented 1.2 g ml −1 L-proline, 285 mg ml −1 -13 C6 15 N2-L-lysine-HCl and 85 mg L -1 -13 C6 15 N2-L-arginine-HCl (Silantes). Time points were collected at 0, 1, 2 and 4 h post addition of SILAC amino acids.
Patient sequencing and enzymology assays
DNA was extracted from skin fibroblasts and whole exome sequencing was performed as published (per subject 1 in reference) [34] . Electron transport chain enzyme activities in skeletal muscle biopsies (post-660g supernatants) and mitochondrial preparations from Epstein-Barr Virus (EBV) transformed lymphocytes (lymphoblasts) were determined spectrophotometrically as previously described [63] . Enzymes assayed were complex I (NADH-coenzyme Q1 oxidoreductase), complex II (succinate-coenzyme Q1 oxidoreductase), complex III (decylbenzylquinol-cytochrome c oxidoreductase), complex IV (cytochrome c oxidase) plus the mitochondrial marker enzyme citrate synthase.
Retroviral transduction
To rescue HIGD2A expression in HIGD2A KO supplemented with 1 mM PMSF and protease inhibitor cocktail (cOmplete™, Merck) on ice. BN-PAGE was performed using mitochondrial protein solubilized in 1% digitonin (w/v) based solubilization buffer as described previously [49, 64] . Mitochondria were isolated as previously described [65] with protein concentration determined In-house polyclonal rabbit antibodies for NDUFA9 were previously described [49] . In-gel activity assays were performed as described previously [40] .
Oxygen consumption measurements
Mitochondrial oxygen consumption rates were measured in live cells using a Seahorse Bioscience XFe-96
Analyzer (Agilent). Briefly, 25,000 cells were plated per well in culture plates treated with 50 µg/mL poly-D-lysine.
For each assay cycle, there were 4 measurements of 2 minutes followed by mixing, 2 minutes wait, and 5 minutes measure. The following inhibitor concentrations were used: 1 µM oligomycin, 1 µM carbonyl cyanide 4- mM. Data were normalized and analyzed as above.
Acquisition and analysis of steady state mass spectrometry data from patient lymphoblasts
Primary lymphoblasts were pre-normalized based on protein concentration using the Pierce Protein Assay Kit (ThermoFisher Scientific). Pellets were solubilized in 1% (w/v) SDC, 100mM Tris pH 8.1, 40mM chloroacetamide (Sigma) and 10 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP; BondBreaker, ThermoFisher Scientific) for 5 min at 99°C with 1500 rpm shaking followed by 15 minutes sonication in a waterbath sonicator. Protein digestion was performed with trypsin (ThermoFisher Scientific) at a 1:50 trypsin:protein ratio at 37°C overnight.
The supernatant was transferred to stagetips containing 3x14G plugs of 3M™Empore™ SDB-RPS substrate (Sigma) as described previously [38, 66] . Ethyl acetate (99% v/v) and 1% (v/v) TFA was added to the tip before The proteinGroups.txt output from the search was processed in Perseus (version 1.6.2.2) [68] . Briefly, Log2transformed LFQ Intensities were grouped into patient or control groups consisting of three controls and two replicates of the patient lymphoblasts. Identifications filtered to include only those that were quantified in at least two samples from each group. Annotations for proteins present in the Mitocarta2.0 dataset [37] were added through matching by gene name. A two-sided t-test with significance determined by permutation-based FDR statistics (FDR 5%, S=0.1) was performed with results expressed as a volcano plot.
Acquisition and analysis of steady state mass spectrometry data from HEK293T cells
Crude mitochondrial protein from HEK293T, HIGD2A KO were added through matching by gene name and rows filtered to include only mitochondrial entries. A two-sided t-test with significance determined by permutation-based FDR statistics (FDR 5%, S=1) was performed with results expressed as a volcano plot. Ratios for individual subunits relative to controls were mapped onto the Cryo-EM PDB maps cited in the figure legends using a custom python script described previously [38] .
Acquisition and analysis of pulse-SILAC mass spectrometry data
Mitochondrial protein pellets were solubilized in 1% (w/v) SDC, 100mM Tris pH 8.1, 40mM chloroacetamide (Sigma) and 10 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP; BondBreaker, ThermoFisher Scientific) for 5 min at 99°C with 1500 rpm shaking followed by 15 minutes sonication in a waterbath sonicator. Protein digestion was performed with trypsin (ThermoFisher Scientific) at a 1:50 trypsin:protein ratio at 37°C overnight.
The supernatant was transferred to stagetips containing 3x14G plugs of 3M™Empore™ SDB-RPS substrate (Sigma) as described previously [38, 66] and above. Analysis of reconstituted peptides was performed by LC MS/MS on a QExactive Plus Orbitrap mass spectrometer (ThermoFisher Scientific) in conjunction with an Ultimate 3000 RSLC nanoHPLC (Dionex Ultimate 3000). The LC system was as described above (Acquisition and analysis of steady state mass spectrometry data from HEK293T cells). For this experiment the mass spectrometer was operated in the data-dependent mode with a targeted inclusion list containing predicted peptides from the 13 mitochondrial DNA-encoded proteins. The inclusion list consists of mass/charge (m/z) and charge (z) of tryptic peptides (endogenous and SILAC labelled) predicted from in-silico digest of target proteins using the Skyline software [69] . In addition, the inclusion list also contained peptides that have been previously observed in public data depositories through the PeptideAtlas site [70] and the present study. Full MS1 spectra were acquired in positive mode, 140,000 resolution, AGC target of 3e 6 
